Dynamic Center
“2017 China BioMed Innovation and Investment Conference” was held in SuZhou Jinji Lake International Conference Center On October 29, 2017. Sichuan Jiuzhang Biotech Co, Ltd (hereafter re...
[View details]
A phase I/II clinical study on Chlorogenic Acid for Injection, a pioneering Class 1 new drug developed by Sichuan Jiuzhang Biotech Co., Ltd., has been incorporated in the NHPLC Major New Drug Innovation Progr...
[View details]
AbstractCancer stem cells (CSCs), also known as tumor-initiating cells (TICs), contribute to tumorigenesis, resistance to chemoradiotherapy and recurrence in human cancers, suggesting targeting CSCs m...
[View details]
AbstractType 2 diabetes (T2D) and cancers are two major causes of morbidity and mortality worldwide. Nowadays, there is convincing evidence of positive associations between T2D and the incidence or pr...
[View details]
